Decreased prevalence of intestinal cryptosporidiosis in HIV-infected patients concomitant to the widespread use of protease inhibitors
Le Moing, V.; Bissuel, F.; Costagliola, D.; Eid, Z.; Chapuis, F.; Molina, J.M.; Salmon-Ceron, D.; Brasseur, P.; Leport, C.
Aids 12(11): 1395-1397
1998
ISSN/ISBN: 0269-9370 PMID: 9708424 Document Number: 533790
Document emailed within 1 workday
Related Documents
Zabek, P.; Opoka-Kegler, J.; Baka, M.; Dyda, T.; Stańczak, G.P.; Stańczak, J.J. 2013: Prevalence of hepatitis C virus mutants resistant to protease inhibitors among Polish HCV genotype 1-infected patients Przeglad Epidemiologiczny 67(3): 411Chronister, C.L.; Gurwood, A.S. 1998: Type 2 diabetes in association with HIV-1 protease inhibitors in HIV-infected patients Journal of the American Optometric Association 69(11): 695-698
Walli, R.; Herfort, O.; Michl, G.M.; Demant, T.; Jäger, H.; Dieterle, C.; Bogner, J.R.; Landgraf, R.; Goebel, F.D. 1998: Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients Aids 12(15): F167-F173
Dionisio, D. 2002: Cryptosporidiosis in HIV-infected patients Journal of Postgraduate Medicine 48(3): 215-216
Moolasart, P.; Eampokalap, B.; Ratanasrithong, M.; Kanthasing, P.; Tansupaswaskul, S.; Tanchanpong, C. 1995: Cryptosporidiosis in HIV infected patients in Thailand Southeast Asian Journal of Tropical Medicine and Public Health 26(2): 335-338
Akinbo, F.O.; Okaka, C.E.; Omoregie, R. 2011: Prevalence of intestinal parasites in relation to CD4 counts and anaemia among HIV-infected patients in Benin City, Edo State, Nigeria Tanzania Journal of Health Research 13(1): 8-13
Choi, J.-y.; Kwon, O.-K.; Choi, S.Y.; Park, Y.K.; Kim, S.S. 2011: Drug susceptibility of human immunodeficiency virus type 1-derived pseudoviruses from treatment-experienced patients to protease inhibitors and reverse transcriptase inhibitors, using a modified single-round assay Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 50(1): 19-25
Mahdi, N.K.; Ali, N.H. 2004: Cryptosporidiosis and other intestinal parasitic infections in patients with chronic diarrhea Saudi Medical Journal 25(9): 1204-1207
Mullakandov, S.A.; Gafarov, E.K.; Nabiev, U.A. 1985: Use of protease inhibitors on burn patients Klinicheskaia Khirurgiia 3: 43-44
Sommadossi; Murphy 1997: Protease Inhibitors Therapy for AIDS Patients Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 1(5): 226-229
Blackman, E.; Binder, S.; Gaultier, C.; Benveniste, R.; Cecilio, M. 1997: Cryptosporidiosis in HIV-infected patients: diagnostic sensitivity of stool examination, based on number of specimens submitted American Journal of Gastroenterology 92(3): 451-453
Armignacco, O.; Andreoni, M.; Sagnelli, E.; Puoti, M.; Bruno, R.; Gaeta, G.Battista.; Perno, C.F.; Santantonio, T.A.; Bonfanti, P.; Bonora, S.; Borderi, M.; Castagna, A.; d'Arminio Monforte, A.; De Luca, A.; Grossi, P.; Guaraldi, G.; Maggiolo, F.; Mussini, C.; Sagnelli, C.; Tavio, M.; Torti, C.; Uberti-Foppa, C.; Andreoni, M.; Angarano, G.; Antinori, A.; Armignacco, O.; Carosi, G.; Chirianni, A.; Di Perri, G.; Galli, M.; Lazzarin, A.; Rizzardini, G.; Sagnelli, E.; Taliani, G. 2014: Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical Disease new microbiologica 37(4): 423-438
Piatkowska, M.; Kotschy, M.; Rość, D.; Wiśniewska, E.; Opoka, J. 1994: Plasma serine protease inhibitors in patients with liver cirrhosis Acta Haematologica Polonica 25(2): 145-149
Swiatkowski, M.; Pulkowski, G.; Kłopocka, M.; Budzyński, J.; Wiśniewsk, E.; Kotschy, M. 2001: Serine protease inhibitors in plasma of patients with ulcerative colitis Przeglad Lekarski 58(2): 67-70
Barthélémy, O.; Escaut, L.; Vayre, F.; Gallet, B.; Pulik, M.; Heloire, F.; Vittecoq, D. 2002: Acute coronary syndromes in patients treated with HIV protease inhibitors Presse Medicale 31(8): 343-348
2003: Are all boosted protease inhibitors the same? Previously treated patients profit too from lopinavir/r MMW Fortschritte der Medizin 145(50): 61
Kłoczko, J.; Bielawiec, M.; Galar, M.; Czaczkowska, T.; Wojtukiewicz, M. 1991: Protein C and plasma serine protease inhibitors in patients with essential hypertension Polski Tygodnik Lekarski 46(50-52): 974-976
Gurgo, A.M.; Massino Ferri, F.; Iulianella, R.; Luciani, C.; Lucifero, A.; Staropoli, P.; Rocchi, M. 2001: Acute myocardial infarct in HIV-positive patients in treatment with protease inhibitors Italian Heart Journal. Suppl: Official Journal of the Italian Federation of Cardiology 2(11): 1236-1239
Sumathi, S.; Pattabiraman, T.N. 1976: Natural plant enzyme inhibitors: Part II-protease inhibitors of seeds Indian Journal of Biochemistry and Biophysics 13(1): 52-56
Bhat, P.G.; Karnik, S.S.; Pattabiraman, T.N. 1976: Natural plant enzyme inhibitors: Part III-purification of protease inhibitors from Lathyrus sativus seeds Indian Journal of Biochemistry and Biophysics 13(4): 339-343